| dc.creator | Novaes, Fernanda S |  | 
| dc.creator | Vasques, Ana C J |  | 
| dc.creator | Pareja, José C |  | 
| dc.creator | Knop, Filip K |  | 
| dc.creator | Tura, Andrea |  | 
| dc.creator | Chaim, Élinton A |  | 
| dc.creator | Geloneze, Bruno |  | 
| dc.date | 2015-Mar |  | 
| dc.date | 2015-11-27T13:46:20Z |  | 
| dc.date | 2015-11-27T13:46:20Z |  | 
| dc.date.accessioned | 2018-03-29T01:23:46Z |  | 
| dc.date.available | 2018-03-29T01:23:46Z |  | 
| dc.identifier | The Journal Of Clinical Endocrinology And Metabolism. , p. jc20144042, 2015-Mar. |  | 
| dc.identifier | 1945-7197 |  | 
| dc.identifier | 10.1210/jc.2014-4042 |  | 
| dc.identifier | http://www.ncbi.nlm.nih.gov/pubmed/25742514 |  | 
| dc.identifier | http://repositorio.unicamp.br/jspui/handle/REPOSIP/202185 |  | 
| dc.identifier | 25742514 |  | 
| dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/1302418 |  | 
| dc.description | Context: Bariatric surgery often results in remission of the diabetic state in obese patients. Increased incretin effect seems to play an important role in the glycemic improvements after Roux-en-Y gastric bypass, but the impact of biliopancreatic diversion (BPD) remains unexplored. Objective: To elucidate the effect of BPD on the incretin effect and its interplay with beta-cell function and insulin sensitivity (IS) in obese subjects with type 2 diabetes (T2DM). Design, Setting and Patients: Twenty-three women were studied: a control group of 13 lean, normal glucose-tolerant women (lean NGT) studied once and 10 obese patients with T2DM studied before, 1 and 12 months after BPD. Intervention: The ObeseT2DM group underwent BPD. Main Outcome Measures: The change in incretin effect as measured by the isoglycemic intravenous glucose infusion test. Secondary outcomes encompassed IS and beta-cell function. Results: At baseline, the incretin effect was lower in obese T2DM compared to lean NGT (p<0.05). One month after BPD, the incretin effect was not changed, but at 12 months it reached the level of the lean NGT group (p>0.05). IS improved (p<0.05) 1 month after BPD and at 12 months it resembled the levels of the lean NGT group. Insulin secretory rate and beta-cell glucose sensitivity increased after BPD and achieved levels similar to lean NGT group 1 month after BPD and even higher levels at 12 months (p<0.05). Conclusions: BPD has no acute impact on the reduced incretin effect, but 12 months after surgery the incretin effect normalizes alongside normalization of glucose control, IS and beta-cell function. |  | 
| dc.description |  |  | 
| dc.description | jc20144042 |  | 
| dc.language | eng |  | 
| dc.relation | The Journal Of Clinical Endocrinology And Metabolism |  | 
| dc.relation | J. Clin. Endocrinol. Metab. |  | 
| dc.rights | fechado |  | 
| dc.rights |  |  | 
| dc.source | PubMed |  | 
| dc.title | Recovery Of The Incretin Effect In Type 2 Diabetic Patients After Biliopancreatic Diversion. |  | 
| dc.type | Artículos de revistas |  |